Human Immunodeficiency Virus Therapeutics Market Share

Report ID: GMI12601
   |
Published Date: December 2024
 | 
Report Format: PDF

Download Free PDF

Human Immunodeficiency Virus Therapeutics Market Share

The worldwide market for human immunodeficiency virus therapeutics manages to be moderately fragmented with the key players having an edge in the market. Vendors like Gilead Sciences, ViiV Healthcare and Bristol Myers Squibb are dominating the market with robust presence owing to their superior products including Truvada, Dolutegravir and Isentress. But the emergence of new competitors and generics has led to a competitive multi-tiered landscape. Lower tier players are increasingly carving out a market presence by targeting specific patient needs like treating resistant strains or by just selling it cheaper.
 

HIV Therapeutics Market Companies

Some of the eminent market participants operating in the human immunodeficiency virus therapeutics industry include:

  • AbbVie
  • Aurobindo Pharma
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • Hetero Drugs
  • Johnson & Johnson
  • Merck & Co
  • Mylan N.V. (Viatris)
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical Industries
  • ViiV Healthcare
     

USP For the Top Players:

  • Broad portfolio covering HIV prevention, treatment, and long-acting formulations.
     
  • Extensive global reach with licensing agreements for generic distribution.
     
  • Collaborative research partnerships with global institutions and pharmaceutical companies.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
How big is the global human immunodeficiency virus therapeutics market?
The global HIV therapeutics industry was valued at USD 39 billion in 2024 and is projected to grow at a 3.5% CAGR from 2025 to 2034, driven by the high incidence of HIV infections and advancements in therapeutic treatments.
What is the market share of branded drugs in the HIV therapeutics industry?
How much revenue did the U.S. generate in the North American HIV therapeutics market in 2024?
Who are some of the prominent players in the HIV therapeutics industry?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2024

    Companies covered: 15

    Tables & Figures: 120

    Countries covered: 18

    Pages: 145

    Download Free PDF

    Top